Delayed Diagnosis and Disseminated Lyme Disease Risk Factors
Delayed diagnosis may increase Lyme disease complications
Access to care may influence disease progression
Disseminated Lyme disease often reflects multiple risk factors
Disseminated Lyme disease risk factors may involve more than the infection itself. Researchers have examined whether barriers to healthcare access, delayed diagnosis, and socioeconomic factors increase the likelihood that Lyme disease progresses beyond the early stage.
Moon and colleagues explored risk factors for disseminated Lyme disease using an electronic database from the Geisinger integrated healthcare system in Pennsylvania. Their analysis relied on both diagnostic coding and narrative clinical data.
What is disseminated Lyme disease?
Disseminated Lyme disease occurs when infection spreads beyond the initial site of infection and involves other organ systems.
One out of three Lyme disease cases in the study were classified as disseminated. Lyme arthritis was the most common manifestation (55%), followed by neurologic manifestations (34%), carditis (6%), and secondary erythema migrans (7%). Another 6% were classified as other manifestations.
Patients with disseminated disease may present differently depending on the body systems involved. Learn more about Lyme disease symptoms and how presentations evolve over time.
In simple terms, disseminated disease means an infection has spread beyond its original location. In Lyme disease, dissemination may involve the joints, nervous system, heart, or multiple body systems.
Why delayed diagnosis increases disseminated Lyme disease risk
This study reinforces earlier Geisinger findings suggesting delayed diagnosis and treatment contribute to more advanced disease presentations.
“Delayed diagnosis and treatment was attributed to appraisal delays (e.g., due to symptom misattribution, intermittent symptoms, atypical or no erythema migrans), behavioral delays in seeking care (e.g., due to inadequate health insurance) and misdiagnosis in urgent care or emergency settings,” wrote the authors.
Delayed diagnosis may occur when patients have atypical symptoms, absent rashes, intermittent illness patterns, or reduced healthcare access.
Read more about delayed Lyme disease diagnosis and how early recognition may affect outcomes.
How socioeconomic status affects Lyme disease outcomes
Individuals with lower socioeconomic status (SES) were more likely to develop disseminated Lyme disease.
An individual was classified as lower SES if they used Medical Assistance at least half of the time. In contrast, individuals utilizing urgent care or maintaining regular relationships with primary care physicians were less likely to develop disseminated Lyme disease.
These findings suggest that healthcare access, continuity of care, and barriers to evaluation may influence disease progression.
What are disseminated Lyme disease symptoms?
Symptoms vary depending on the organs involved. Disseminated Lyme disease symptoms may include:
- Joint swelling or Lyme arthritis
- Neurologic symptoms
- Cardiac manifestations
- Multiple erythema migrans lesions
- Persistent fatigue or cognitive symptoms
These symptoms may overlap with findings described in neurologic Lyme disease and other later manifestations.
Study limitations
The study had several limitations, including disease staging challenges and retrospective review of records.
The authors also noted they could not reliably assess atypical or absent rashes, which may contribute to delayed diagnosis.
They concluded, “Intervening on these factors could reduce the individual and healthcare burden of disseminated Lyme disease.”
Frequently Asked Questions
What is disseminated Lyme disease?
Disseminated Lyme disease refers to infection that has spread beyond early localized disease and may affect joints, nerves, the heart, or multiple body systems.
What increases the risk of disseminated Lyme disease?
Delayed diagnosis, healthcare barriers, atypical symptoms, and reduced continuity of care may increase risk.
What are common disseminated Lyme disease symptoms?
Symptoms may include arthritis, neurologic symptoms, cardiac involvement, multiple rashes, fatigue, and cognitive complaints.
Can delayed diagnosis increase Lyme disease complications?
Delayed diagnosis may increase the likelihood of more widespread disease manifestations and prolonged illness.
Clinical Takeaway
Disseminated Lyme disease may reflect more than biologic factors alone. Access to care, early recognition, and continuity of medical care may influence outcomes.
Reducing diagnostic delays and barriers to care may lower the risk of disseminated Lyme disease and its complications.
Related Articles
Delayed Lyme disease diagnosis
Lyme disease misdiagnosis
Persistent Lyme disease mechanisms
Ocular Lyme disease
References
- Moon KA, Pollak JS, Poulsen MN, Heaney CD, Hirsch AG, Schwartz BS. Risk factors for Lyme disease stage and manifestation using electronic health records. BMC Infect Dis. 2021;21(1):1269.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
When the average cost of treatment is out of pocket and minimal around USD 10 K in the USA, and many are spending five to ten times that, its no wonder its a poor man’s disease ? We really need patient rights respected and health care policy written by patients rights advocates and true scientists not insurance companies or corrupted medical associations working with pharmaceutical companies profiting from treating symptoms in untested or poorly tested and undiagnosed poor.